Solid Biosciences LLC
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1,235 | -327 | ||
EBITDA | -42,034 | -35,182 | -23,749 | -23,881 |
EBIT | -42,522 | -35,587 | -24,984 | -24,208 |
Net Income | -42,597 | -32,725 | -25,072 | -24,303 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -29,849 | -23,723 | -21,753 | -25,341 |
Cash | 80,235 | 64,394 | 95,854 | 117,574 |
Basic Shares | 40,816 | 41,443 | 40,934 | 38,155 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $8,094 | $13,620 |
Gross Profit | -76,563 | 5,686 | -45,119 | |
EBITDA | -129,728 | -93,434 | -96,866 | -69,290 |
EBIT | -96,015 | -99,274 | -72,254 | |
Net Income | -124,697 | -96,015 | -65,510 | -72,124 |
Net Change In Cash | 0 | 0 | 8,094 | 13,620 |
Cost of Revenue | 36,011 | -33,865 | ||
Free Cash Flow | -100,666 | -95,695 | -100,992 | -79,045 |
Cash | 80,235 | 74,015 | 155,384 | 119,136 |
Basic Shares | 40,816 | 19,884 | 8,512 | 7,118 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1 |
2024-09-30 | -$0.79 |
2024-06-30 | -$0.61 |
2024-03-31 | -$0.64 |
